Interest Expense of Perspective Therapeutics, Inc. from 30 Jun 2013 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Perspective Therapeutics, Inc. quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2013 to 31 Dec 2023.
  • Perspective Therapeutics, Inc. Interest Expense for the quarter ending 31 Dec 2023 was $59,916.
  • Perspective Therapeutics, Inc. Interest Expense for the twelve months ending 31 Dec 2023 was $84.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2023 was $84.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2022 was $0.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2017 was $0, a 100% decline from 2016.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Perspective Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $84 $59,916 -$59,916 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q3 2023 $60,000 $14,000 +$14,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $46,000 $28,000 +$28,000 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $18,000 $18,000 +$18,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $0 $0 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q2 2016 $1,000 $50 +$1,601 01 Apr 2016 30 Jun 2016 10-K 26 Sep 2018 2018 FY
Q1 2016 $601 $0 -$100 -100% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $501 $0 $0 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $501 $950 -$2,501 -72% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $2,000 $1,551 01 Apr 2015 30 Jun 2015 10-K 28 Sep 2017 2017 FY
Q1 2015 $100 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q3
Q4 2014 $0 -$86 -100% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 $3,451 +$2,710 +366% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q4 2013 $86 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q2
Q3 2013 $741 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q1

Perspective Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $84 +$84 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $0 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2017 $0 -$1,000 -100% 01 Jul 2016 30 Jun 2017 10-K 28 Sep 2017 2017 FY
2016 $1,000 -$1,000 -50% 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018 2018 FY
2015 $2,000 +$1,117 +127% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2017 2017 FY
2014 $883 +$876 +12514% 01 Jul 2013 30 Jun 2014 10-K 09 Sep 2016 2016 FY
2013 $7 01 Jul 2012 30 Jun 2013 10-K 14 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.